Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study.

Conde E, Hernandez S, Martinez R, Angulo B, De Castro J, Collazo-Lorduy A, Jimenez B, Muriel A, Mate JL, Moran T, Aranda I, Massuti B, Rojo F, Domine M, Sansano I, Garcia F, Felip E, Mancheño N, Juan O, Sanz J, Gonzalez-Larriba JL, Atienza-Cuevas L, Arriola-Arellano E, Abdulkader I, Garcia-Gonzalez J, Camacho C, Rodriguez-Abreu D, Teixido C, Reguart N, Gonzalez-Piñeiro A, Lazaro-Quintela M, Lozano MD, Gurpide A, Gomez-Roman J, Lopez-Brea M, Pijuan L, Salido M, Arriola E, Company A, Insa A, Esteban-Rodriguez I, Saiz M, Azkona E, Alvarez R, Artal A, Plaza ML, Aguiar D, Enguita AB, Benito A, Paz-Ares L, Garrido P, Lopez-Rios F.

J Thorac Oncol. 2019 Jul 23. pii: S1556-0864(19)30562-3. doi: 10.1016/j.jtho.2019.07.005. [Epub ahead of print]

2.

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study.

Richi P, Martín MD, Navío MT, González-Hombrado L, Salido M, Llorente J, Thuissard-Vasallo I, Alcocer P, Saa-Requejo CM, Jiménez-Diaz A, Cebrián L, Lojo L, García-Castro M, Sanz-Rosa D, Castro P, Fernández-Rodríguez S, Martínez de Aramayona MJ, Steiner M, Cobo T, García-Fernández C, Fernández-Castro M, Illera Ó, Valverde R, Muñoz-Fernández S.

Med Clin (Barc). 2019 May 3. pii: S0025-7753(19)30130-7. doi: 10.1016/j.medcli.2019.02.003. [Epub ahead of print] English, Spanish.

PMID:
31060878
3.

Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.

Clavé S, Rodon N, Pijuan L, Díaz O, Lorenzo M, Rocha P, Taus Á, Blanco R, Bosch-Barrera J, Reguart N, de la Torre N, Oliveras G, Espinet B, Bellosillo B, Puig X, Arriola E, Salido M.

Clin Lung Cancer. 2019 Jul;20(4):e421-e429. doi: 10.1016/j.cllc.2019.02.008. Epub 2019 Feb 26.

PMID:
30898567
4.

The MapZ-Mediated Methylation of Chemoreceptors Contributes to Pathogenicity of Pseudomonas aeruginosa.

Sheng S, Xin L, Yam JKH, Salido MM, Khong NZJ, Liu Q, Chea RA, Li HY, Yang L, Liang ZX, Xu L.

Front Microbiol. 2019 Feb 5;10:67. doi: 10.3389/fmicb.2019.00067. eCollection 2019.

5.

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents.

Yuan M, Chua SL, Liu Y, Drautz-Moses DI, Yam JKH, Aung TT, Beuerman RW, Salido MMS, Schuster SC, Tan CH, Givskov M, Yang L, Nielsen TE.

Beilstein J Org Chem. 2018 Dec 14;14:3059-3069. doi: 10.3762/bjoc.14.284. eCollection 2018.

6.

Original vs. non-original abutments for screw-retained single implant crowns: An in vitro evaluation of internal fit, mechanical behaviour and screw loosening.

Alonso-Pérez R, Bartolomé JF, Ferreiroa A, Salido MP, Pradíes G.

Clin Oral Implants Res. 2018 Dec;29(12):1230-1238. doi: 10.1111/clr.13390. Epub 2018 Dec 7.

PMID:
30537302
7.

Comparative study of all-ceramic crowns obtained from conventional and digital impressions: clinical findings.

Berrendero S, Salido MP, Ferreiroa A, Valverde A, Pradíes G.

Clin Oral Investig. 2019 Apr;23(4):1745-1751. doi: 10.1007/s00784-018-2606-8. Epub 2018 Aug 30.

PMID:
30167795
8.

Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma.

Taus Á, Camacho L, Rocha P, Hardy-Werbin M, Pijuan L, Piquer G, López E, Dalmases A, Longarón R, Clavé S, Salido M, Albanell J, Bellosillo B, Arriola E.

Clin Lung Cancer. 2018 Sep;19(5):387-394.e2. doi: 10.1016/j.cllc.2018.03.015. Epub 2018 Mar 23.

PMID:
29656868
9.

Factors associated with severe sepsis or septic shock in complicated pyelonephritis.

Ruiz-Mesa JD, Marquez-Gomez I, Sena G, Buonaiuto VA, Ordoñez JM, Salido M, Ciézar AP, Santis LV, Mediavilla C, Colmenero JD.

Medicine (Baltimore). 2017 Oct;96(43):e8371. doi: 10.1097/MD.0000000000008371.

10.

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions.

Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz-Xivillé N, Rivas-Delgado A, Luño E, González T, Navarro B, García-Malo M, Valiente A, Hernández JÁ, Ardanaz MT, Piñan MÁ, Blanco ML, Hernández-Sánchez M, Batlle-López A, Salgado R, Salido M, Ferrer A, Abrisqueta P, Gimeno E, Abella E, Ferrá C, Terol MJ, Ortuño F, Costa D, Moreno C, Carbonell F, Bosch F, Delgado J, Espinet B.

Oncotarget. 2017 Apr 21;8(33):54297-54303. doi: 10.18632/oncotarget.17350. eCollection 2017 Aug 15.

11.

The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence.

Wang K, Chen YQ, Salido MM, Kohli GS, Kong JL, Liang HJ, Yao ZT, Xie YT, Wu HY, Cai SQ, Drautz-Moses DI, Darling AE, Schuster SC, Yang L, Ding Y.

Open Biol. 2017 Sep;7(9). pii: 170029. doi: 10.1098/rsob.170029.

12.

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Sabbaghi M, Gil-Gómez G, Guardia C, Servitja S, Arpí O, García-Alonso S, Menendez S, Arumi-Uria M, Serrano L, Salido M, Muntasell A, Martínez-García M, Zazo S, Chamizo C, González-Alonso P, Madoz-Gúrpide J, Eroles P, Arribas J, Tusquets I, Lluch A, Pandiella A, Rojo F, Rovira A, Albanell J.

Clin Cancer Res. 2017 Nov 15;23(22):7006-7019. doi: 10.1158/1078-0432.CCR-17-0696. Epub 2017 Aug 18.

13.

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

Clavé S, Pijuan L, Casadevall D, Taus Á, Gimeno J, Hernández-Llodrà S, Rodríguez-Rivera M, Lorenzo M, Menéndez S, Albanell J, Espinet B, Arriola E, Salido M.

Histopathology. 2018 Jan;72(2):259-269. doi: 10.1111/his.13339. Epub 2017 Oct 27.

PMID:
28795418
14.

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.

Casadevall D, Clavé S, Taus Á, Hardy-Werbin M, Rocha P, Lorenzo M, Menéndez S, Salido M, Albanell J, Pijuan L, Arriola E.

Clin Lung Cancer. 2017 Nov;18(6):682-691.e5. doi: 10.1016/j.cllc.2017.04.014. Epub 2017 May 4.

PMID:
28549836
15.

Evaluation of the Mechanical Behavior and Marginal Accuracy of Stock and Laser-Sintered Implant Abutments.

Alonso-Pérez R, Bartolomé JF, Ferreiroa A, Salido MP, Pradíes G.

Int J Prosthodont. 2017 Mar/Apr;30(2):136-138. doi: 10.11607/ijp.5089.

PMID:
28267820
16.

A Clinical Study Assessing the Influence of Anodized Titanium and Zirconium Dioxide Abutments and Peri-implant Soft Tissue Thickness on the Optical Outcome of Implant-Supported Lithium Disilicate Single Crowns.

Martínez-Rus F, Prieto M, Salido MP, Madrigal C, Özcan M, Pradíes G.

Int J Oral Maxillofac Implants. 2017 Jan/Feb;32(1):156-163. doi: 10.11607/jomi.5258.

PMID:
28095519
17.

Intracellular Elemental Patterns of Apoptosis Resistance in Transdifferentiated Androgen-Dependent Prostatic Carcinoma Cells.

Salido M, Vilches J.

Microsc Microanal. 2016 Aug;22(4):865-77. doi: 10.1017/S1431927616011454. Epub 2016 Aug 4.

PMID:
27487730
18.

In vitro comparison of the accuracy (trueness and precision) of six extraoral dental scanners with different scanning technologies.

González de Villaumbrosia P, Martínez-Rus F, García-Orejas A, Salido MP, Pradíes G.

J Prosthet Dent. 2016 Oct;116(4):543-550.e1. doi: 10.1016/j.prosdent.2016.01.025. Epub 2016 Apr 23.

PMID:
27112413
19.

Hyperpigmentation following the Blaschko's lines: a subtle cutaneous manifestation of Turner syndrome with complex mosaicism.

Deza G, López Aventín D, Salido M, Espinet B, Gilaberte M, Pujol RM.

Br J Dermatol. 2016 Dec;175(6):1379-1381. doi: 10.1111/bjd.14688. Epub 2016 Oct 7. No abstract available.

PMID:
27106053
20.

Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.

Hernández S, Font-Tello A, Juanpere N, de Muga S, Lorenzo M, Salido M, Fumadó L, Serrano L, Cecchini L, Serrano S, Lloreta J.

Prostate. 2016 Jun;76(9):854-65. doi: 10.1002/pros.23176. Epub 2016 Mar 9.

PMID:
26959281
21.

Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.

Chua SL, Yam JK, Hao P, Adav SS, Salido MM, Liu Y, Givskov M, Sze SK, Tolker-Nielsen T, Yang L.

Nat Commun. 2016 Feb 19;7:10750. doi: 10.1038/ncomms10750.

22.

Influence of conventional and digital intraoral impressions on the fit of CAD/CAM-fabricated all-ceramic crowns.

Berrendero S, Salido MP, Valverde A, Ferreiroa A, Pradíes G.

Clin Oral Investig. 2016 Dec;20(9):2403-2410. doi: 10.1007/s00784-016-1714-6. Epub 2016 Jan 23.

PMID:
26800669
23.

ROS1 copy number alterations are frequent in non-small cell lung cancer.

Clavé S, Gimeno J, Muñoz-Mármol AM, Vidal J, Reguart N, Carcereny E, Pijuan L, Menéndez S, Taus Á, Mate JL, Serrano S, Albanell J, Espinet B, Arriola E, Salido M.

Oncotarget. 2016 Feb 16;7(7):8019-28. doi: 10.18632/oncotarget.6921.

24.

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).

Casadevall D, Gimeno J, Clavé S, Taus Á, Pijuan L, Arumí M, Lorenzo M, Menéndez S, Cañadas I, Albanell J, Serrano S, Espinet B, Salido M, Arriola E.

Oncotarget. 2015 Jun 30;6(18):16215-26.

25.

Complete Genome Sequence and Transcriptomic Analysis of the Novel Pathogen Elizabethkingia anophelis in Response to Oxidative Stress.

Li Y, Liu Y, Chew SC, Tay M, Salido MM, Teo J, Lauro FM, Givskov M, Yang L.

Genome Biol Evol. 2015 May 26;7(6):1676-85. doi: 10.1093/gbe/evv101.

26.

Guidelines for cytogenetic investigations in tumours.

Hastings RJ, Bown N, Tibiletti MG, Debiec-Rychter M, Vanni R, Espinet B, van Roy N, Roberts P, van den Berg-de-Ruiter E, Bernheim A, Schoumans J, Chatters S, Zemanova Z, Stevens-Kroef M, Simons A, Heim S, Salido M, Ylstra B, Betts DR; Tumour Best Practice meeting; Eurogentest.

Eur J Hum Genet. 2016 Jan;24(1):6-13. doi: 10.1038/ejhg.2015.35. Epub 2015 Mar 25. No abstract available.

27.

HER2 as a target in invasive urothelial carcinoma.

Bellmunt J, Werner L, Bamias A, Fay AP, Park RS, Riester M, Selvarajah S, Barletta JA, Berman DM, de Muga S, Salido M, Gallardo E, Rojo F, Guancial EA, Bambury R, Mullane SA, Choueiri TK, Loda M, Stack E, Rosenberg J.

Cancer Med. 2015 Jun;4(6):844-52. doi: 10.1002/cam4.432. Epub 2015 Feb 26.

28.

Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer.

Arena S, Bellosillo B, Siravegna G, Martínez A, Cañadas I, Lazzari L, Ferruz N, Russo M, Misale S, González I, Iglesias M, Gavilan E, Corti G, Hobor S, Crisafulli G, Salido M, Sánchez J, Dalmases A, Bellmunt J, De Fabritiis G, Rovira A, Di Nicolantonio F, Albanell J, Bardelli A, Montagut C.

Clin Cancer Res. 2015 May 1;21(9):2157-66. doi: 10.1158/1078-0432.CCR-14-2821. Epub 2015 Jan 26.

29.

Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.

Vidal J, Clavé S, de Muga S, González I, Pijuan L, Gimeno J, Remón J, Reguart N, Viñolas N, Gironés R, Bernet L, Majem M, Bosch-Barrera J, Porta R, Alonso N, Palmero R, Taus A, Albanell J, Espinet B, Salido M, Arriola E.

J Thorac Oncol. 2014 Dec;9(12):1816-20. doi: 10.1097/JTO.0000000000000361.

30.

Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status.

Nadal R, Salido M, Nonell L, Rodríguez-Rivera M, Puigdecanet E, Garcia-Puche JL, Macià M, Corominas JM, Serrano MJ, Lorente JA, Solé F.

Tumour Biol. 2015 Feb;36(2):711-8. doi: 10.1007/s13277-014-2668-4. Epub 2014 Oct 7.

PMID:
25286758
31.

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.

Serrano MJ, Ortega FG, Alvarez-Cubero MJ, Nadal R, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Delgado-Rodriguez M, Solé F, García MA, Perán M, Rosell R, Marchal JA, Lorente JA.

Oncotarget. 2014 Sep 15;5(17):7486-97.

32.

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.

Conde E, Suárez-Gauthier A, Benito A, Garrido P, García-Campelo R, Biscuola M, Paz-Ares L, Hardisson D, de Castro J, Camacho MC, Rodriguez-Abreu D, Abdulkader I, Ramirez J, Reguart N, Salido M, Pijuán L, Arriola E, Sanz J, Folgueras V, Villanueva N, Gómez-Román J, Hidalgo M, López-Ríos F.

PLoS One. 2014 Sep 23;9(9):e107200. doi: 10.1371/journal.pone.0107200. eCollection 2014.

33.

Translocation t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin.

Xochelli A, Baliakas P, Moore S, Sole F, Wickham N, Salido M, Athanasiadou A, Oscier D, Stamatopoulos K.

Cancer Genet. 2014 Jun;207(6):281-3. doi: 10.1016/j.cancergen.2014.06.026. Epub 2014 Jun 25. No abstract available.

PMID:
25178943
34.

Identification of ALK gene alterations in urothelial carcinoma.

Bellmunt J, Selvarajah S, Rodig S, Salido M, de Muga S, Costa I, Bellosillo B, Werner L, Mullane S, Fay AP, O'Brien R, Barretina J, Minoche AE, Signoretti S, Montagut C, Himmelbauer H, Berman DM, Kantoff P, Choueiri TK, Rosenberg JE.

PLoS One. 2014 Aug 1;9(8):e103325. doi: 10.1371/journal.pone.0103325. eCollection 2014.

35.

Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.

Puiggros A, Venturas M, Salido M, Blanco G, Fernandez-Rodriguez C, Collado R, Valiente A, Ruiz-Xivillé N, Carrió A, Ortuño FJ, Luño E, Calasanz MJ, Ardanaz MT, Piñán MÁ, Talavera E, González MT, Ortega M, Marugán I, Ferrer A, Gimeno E, Bellosillo B, Delgado J, Hernández JÁ, Hernández-Rivas JM, Espinet B; Grupo Cooperativo Español de Citogenética Hematológica (GCECGH); Grupo Español de Leucemia Linfática Crónica (GELLC).

Genes Chromosomes Cancer. 2014 Sep;53(9):788-97. doi: 10.1002/gcc.22188. Epub 2014 Jun 10.

PMID:
24915757
36.

Osteoconductive potential of barrier nanoSiO2 PLGA membranes functionalized by plasma enhanced chemical vapour deposition.

Terriza A, Vilches-Pérez JI, de la Orden E, Yubero F, Gonzalez-Caballero JL, González-Elipe AR, Vilches J, Salido M.

Biomed Res Int. 2014;2014:253590. doi: 10.1155/2014/253590. Epub 2014 May 4.

37.

Osteoblasts Interaction with PLGA Membranes Functionalized with Titanium Film Nanolayer by PECVD. In vitro Assessment of Surface Influence on Cell Adhesion during Initial Cell to Material Interaction.

Terriza A, Vilches-Pérez JI, González-Caballero JL, Orden E, Yubero F, Barranco A, Gonzalez-Elipe AR, Vilches J, Salido M.

Materials (Basel). 2014 Mar 4;7(3):1687-1708. doi: 10.3390/ma7031687.

38.

Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.

Cañadas I, Rojo F, Taus Á, Arpí O, Arumí-Uría M, Pijuan L, Menéndez S, Zazo S, Dómine M, Salido M, Mojal S, García de Herreros A, Rovira A, Albanell J, Arriola E.

Clin Cancer Res. 2014 Feb 15;20(4):938-50. doi: 10.1158/1078-0432.CCR-13-1330. Epub 2013 Nov 27.

39.

CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.

Nadal R, Ortega FG, Salido M, Lorente JA, Rodríguez-Rivera M, Delgado-Rodríguez M, Macià M, Fernández A, Corominas JM, García-Puche JL, Sánchez-Rovira P, Solé F, Serrano MJ.

Int J Cancer. 2013 Nov 15;133(10):2398-407. doi: 10.1002/ijc.28263. Epub 2013 Jul 6.

40.

Directed pancreatic acinar differentiation of mouse embryonic stem cells via embryonic signalling molecules and exocrine transcription factors.

Delaspre F, Massumi M, Salido M, Soria B, Ravassard P, Savatier P, Skoudy A.

PLoS One. 2013;8(1):e54243. doi: 10.1371/journal.pone.0054243. Epub 2013 Jan 17.

41.

Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?

Ademà V, Hernández JM, Abáigar M, Lumbreras E, Such E, Calull A, Dominguez E, Arenillas L, Mallo M, Cervera J, Marugán I, Tormo M, García F, González T, Luño E, Sanzo C, Martín ML, Fernández M, Costa D, Blázquez B, Barreña B, Marco F, Batlle A, Buño I, Martínez-Laperche C, Noriega V, Collado R, Ivars D, Carbonell F, Vallcorba I, Melero J, Delgado E, Vargas MT, Grau J, Salido M, Espinet B, Melero C, Florensa L, Pedro C, Solé F.

Leuk Res. 2013 Apr;37(4):416-21. doi: 10.1016/j.leukres.2012.12.010. Epub 2013 Jan 18.

PMID:
23337401
42.

CXCR4 mRNA overexpression in high grade prostate tumors: lack of association with TMPRSS2-ERG rearrangement.

de Muga S, Hernández S, Salido M, Lorenzo M, Agell L, Juanpere N, Lorente JA, Serrano S, Lloreta J.

Cancer Biomark. 2012-2013;12(1):21-30. doi: 10.3233/CBM-2012-00288.

PMID:
23321466
43.

MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma.

Masferrer E, Ferrándiz-Pulido C, Lloveras B, Masferrer-Niubò M, Espinet B, Salido M, Rodríguez-Rivera M, Alemany L, Placer J, Gelabert A, Servitje O, García-Patos V, Pujol RM, Toll A.

J Urol. 2012 Nov;188(5):1965-71. doi: 10.1016/j.juro.2012.07.003. Epub 2012 Sep 20.

PMID:
22999547
44.

Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?

Puiggros A, Puigdecanet E, Salido M, Ferrer A, Abella E, Gimeno E, Nonell L, Herranz MJ, Galván AB, Rodríguez-Rivera M, Melero C, Pairet S, Bellosillo B, Serrano S, Florensa L, Solé F, Espinet B.

Leuk Lymphoma. 2013 May;54(5):986-95. doi: 10.3109/10428194.2012.731598. Epub 2012 Oct 16.

PMID:
22994157
45.

Light induced hydrophilicity and osteoblast adhesion promotion on amorphous TiO2.

Terriza A, Díaz-Cuenca A, Yubero F, Barranco A, González-Elipe AR, Gonzalez Caballero JL, Vilches J, Salido M.

J Biomed Mater Res A. 2013 Apr;101(4):1026-35. doi: 10.1002/jbm.a.34405. Epub 2012 Sep 11.

PMID:
22965473
46.

Prospective clinical study of zirconia-based posterior four-unit fixed dental prostheses: four-year follow-up.

Salido MP, Martinez-Rus F, del Rio F, Pradies G, Ozcan M, Suarez MJ.

Int J Prosthodont. 2012 Jul-Aug;25(4):403-9.

PMID:
22720293
47.

Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.

Carracedo A, Salido M, Corominas JM, Rojo F, Ferreira BI, Suela J, Tusquets I, Corzo C, Segura M, Espinet B, Cigudosa JC, Arumi M, Albanell J, Serrano S, Solé F.

Cancer Genet. 2012 Apr;205(4):138-46. doi: 10.1016/j.cancergen.2012.01.001.

PMID:
22559974
48.

Biomarkers characterization of circulating tumour cells in breast cancer patients.

Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Macià M, Corominas JM, Delgado-Rodriguez M, Gonzalez L, Albanell J, Fernández M, Solé F, Lorente JA, Serrano MJ.

Breast Cancer Res. 2012 May 3;14(3):R71.

49.

Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.

Alameda F, Juanpere N, Pijuan L, Lloveras B, Gimeno J, Baró T, Salido M, Serrano S, Lloreta J.

Cancer Cytopathol. 2012 Aug 25;120(4):276-82. doi: 10.1002/cncy.21193. Epub 2012 Mar 14.

50.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.

Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, Salido M, Gallen M, Marsters S, Tsai SP, Minoche A, Seshagiri S, Serrano S, Himmelbauer H, Bellmunt J, Rovira A, Settleman J, Bosch F, Albanell J.

Nat Med. 2012 Jan 22;18(2):221-3. doi: 10.1038/nm.2609. Erratum in: Nat Med. 2012 Sep;18(9):1445. Somasekar, Seshagiri [corrected to Seshagiri, Somasekar].

PMID:
22270724

Supplemental Content

Loading ...
Support Center